| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.097 | 0.0006 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.099 | 0.0007 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |